NivolumabCRCHead and Neck CarcinomaBreast CarcinomaColorectal cancerRCCRenal Cell Carcinoma
…e target for nivolumab, in CRC (n=4), RCC (n=2) and CaBr (n=3), Nivolumab treatment induced increase in proportion of activated effector …
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 52 of 2459CAN-2409docetaxelNSCLCsacituzumab govitecanvalacyclovir
…histology displayed a more pronounced immunological response to CAN-2409 treatment compared to patients with SQ histology. Improved immu…
rituximabtocilizumabMemorial Sloan Kettering Cancer Center Institutional Review Boardbullous pemphigoidprednisoneColumbia University Institutional Review Boardarthritisosteoporosis
…atients were enrolled based on published data supporting use of rituximab or tocilizumab. Each arm aimed to enroll 15 patients. Primary e…
TNG260pembrolizumabNSCLC
…by TNG260 sensitizes STK11-mutant tumors to anti-PD1 treatment. TNG260, in combination with pembrolizumab, is being evaluated in a pha…
neuroblastomaGlioblastomaGBMNKTR-255
…hbehani GK, Riddell S, Cripe T, Cairo MS. Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vit…
asthmainhaled corticosteroidsNational Institute for Health and Care ExcellenceICSNICE
… guidelines result in a significantly higher number of positive asthma diagnosis being made in children. After removing the need for o…
peripheral artery diseaseischaemic heart diseasediabetesuveitisheart failuremyocardial infarctioncardiovascular diseasestroke
…: education: 1.72 (1.33 to 2.23); income: 2.15 (1.65 to 2.79)), peripheral artery disease (low status: education 2.87 (1.77 to 4.68); intermediate status…
DKAtype 1 diabetesCOVID-19diabetic ketoacidosisT1D
…nset (76.4%), with a significant proportion experiencing severe DKA (33.6%). Factors like age, sex, season, glycaemia, glycated hae…
citaloprambupropionalaproclatemilnacipranfluvoxaminevilazodonemirtazapineagomelatinereboxetinedesvenlafaxine+8 more
…ssants will be considered: agomelatine, alaproclate, bupropion, citalopram, desvenlafaxine, duloxetine, edivoxetine, escitalopram, fluoxet…
Chronic Liver Disease QuestionnaireAdvCLDchronic inflammatory diseaseChronic liver diseaseliver transplantCIDAdvLD
…teristics, disease severity (UKELD), and quality of life (QoL) (Chronic liver disease questionnaire [CLDQ]) were recorded. Sleep window, sleep onset, the midpoint …
hepatocellular carcinomaHCCviral hepatitisSLD
…policy-statement-risk-basedFan, et al. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. J Hepatol. 2020…
cancerParkinson’s diseasechronic-progressive diseaseorgan failurestrokedementia
…e was the lowest (IRR 0.70 (95% CI 0.68 to 0.73)). Persons with cancer had the highest rate (IRR 1.75 (95% CI 1.68 to 1.83)). Within t…